130 related articles for article (PubMed ID: 1936795)
1. Central and peripheral control of postprandial pyloric motility by endogenous opiates and cholecystokinin in dogs.
Lopez Y; Fioramonti J; Bueno L
Gastroenterology; 1991 Nov; 101(5):1249-55. PubMed ID: 1936795
[TBL] [Abstract][Full Text] [Related]
2. Involvement of endogenous opiates in regulation of gastric emptying of fat test meals in mice.
Fioramonti J; Fargeas MJ; Bueno L
Am J Physiol; 1988 Aug; 255(2 Pt 1):G158-61. PubMed ID: 3407774
[TBL] [Abstract][Full Text] [Related]
3. Action of endogenous prostaglandins on postprandial pyloric motility: a possible modulation by fats.
Lopez Y; Fioramonti J; Bueno L
Prostaglandins; 1991 Oct; 42(4):313-20. PubMed ID: 1796147
[TBL] [Abstract][Full Text] [Related]
4. Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.
Tanaka T; Mizumoto A; Muramatsu S; Mochiki E; Haga N; Suzuki H; Itoh Z
Dig Dis Sci; 1999 Aug; 44(8):1516-24. PubMed ID: 10492127
[TBL] [Abstract][Full Text] [Related]
5. Opiate nerves mediate feline pyloric response to intraduodenal amino acids.
Reynolds JC; Ouyang A; Cohen S
Am J Physiol; 1985 Mar; 248(3 Pt 1):G307-12. PubMed ID: 3976889
[TBL] [Abstract][Full Text] [Related]
6. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
[TBL] [Abstract][Full Text] [Related]
7. Role of cholecystokinin in postprandial and vagally stimulated duodenal and gallbladder motility in dogs.
Thor P; Laskiewcz J; Maczka M; Konturek SJ
J Physiol Pharmacol; 1991 Dec; 42(4):381-8. PubMed ID: 1824297
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites.
Moran TH; Kornbluh R; Moore K; Schwartz GJ
Regul Pept; 1994 Aug; 52(3):165-72. PubMed ID: 7800848
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
[TBL] [Abstract][Full Text] [Related]
10. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
[TBL] [Abstract][Full Text] [Related]
11. Postprandial peptide YY release is mediated by cholecystokinin.
McFadden DW; Rudnicki M; Kuvshinoff B; Fischer JE
Surg Gynecol Obstet; 1992 Aug; 175(2):145-50. PubMed ID: 1636140
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and central cholecystokinin receptors regulate postprandial intestinal motility in the rat.
Rodríguez-Membrilla A; Martínez V; Vergara P
J Pharmacol Exp Ther; 1995 Oct; 275(1):486-93. PubMed ID: 7562590
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
14. Role of hypothalamic cholecystokinin octapeptide in the colonic motor response to a meal in rats.
Liberge M; Arruebo MP; Bueno L
Gastroenterology; 1991 Feb; 100(2):441-9. PubMed ID: 1985040
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a role of endogenous opiates in postprandial somatostatin release.
Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
Regul Pept; 1983 Aug; 6(4):355-61. PubMed ID: 6138819
[TBL] [Abstract][Full Text] [Related]
16. Role of cholecystokinin in the gastric motor response to a meal in horses.
Lorenzo-Figueras M; Merritt AM
Am J Vet Res; 2006 Dec; 67(12):1998-2005. PubMed ID: 17144800
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cholecystokinin in the control of gastric emptying of liquid nutrient loads in rhesus monkeys.
Moran TH; Ameglio PJ; Schwartz GJ; Peyton HJ; McHugh PR
Am J Physiol; 1993 Aug; 265(2 Pt 2):R371-5. PubMed ID: 8368391
[TBL] [Abstract][Full Text] [Related]
18. Involvement of different mechanisms in the stimulatory effects of cholecystokinin octapeptide on gastrointestinal and colonic motility in dogs.
Fargeas MJ; Bassotti G; Fioramonti J; Bueno L
Can J Physiol Pharmacol; 1989 Oct; 67(10):1205-12. PubMed ID: 2611718
[TBL] [Abstract][Full Text] [Related]
19. Opposite central and peripheral control by endogenous opioids of intestinal motility in fed rats.
Rivière PJ; Liberge M; Murillo-Lopez D; Bueno L
Br J Pharmacol; 1989 Sep; 98(1):236-42. PubMed ID: 2679957
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion.
Lloyd KC; Maxwell V; Kovacs TO; Miller J; Walsh JH
Gastroenterology; 1992 Jan; 102(1):131-8. PubMed ID: 1727746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
